| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.914 | 0.004 | 0.914 | Antiobesity | 0.842 0.005 CID_134772 | ||
| 0.9 | 0.002 | 0.9 | 5 Hydroxytryptamine uptake inhibitor | 0.696 0.003 CID_134772 | ||
| 0.847 | 0.002 | 0.847 | Adrenaline uptake inhibitor | 0.668 0.003 CID_134772 | ||
| 0.546 | 0.002 | 0.546 | Dopamine transporter inhibitor | 0.469 0.003 CID_134772 | ||
| 0.56 | 0.019 | 0.56 | 5 Hydroxytryptamine release stimulant | 0.549 0.02 CID_134772 | ||
| 0.493 | 0.003 | 0.493 | Dopamine uptake inhibitor | 0.345 0.004 CID_134772 | ||
| 0.353 | 0.023 | 0.366 | Anesthetic general | 0.366 0.021 CID_134772 | CID_134772 | |
| 0.378 | 0.054 | 0.399 | Cholesterol antagonist | 0.399 0.05 CID_134772 | CID_134772 | |
| 0.337 | 0.029 | 0.487 | 5 Hydroxytryptamine uptake stimulant | 0.487 0.005 CID_134772 | CID_134772 | |
| 0.336 | 0.04 | 0.336 | Potassium channel (Voltage-sensitive) blocker | 0.177 0.114 CID_134772 | ||
| 0.334 | 0.058 | 0.465 | Aldehyde oxidase inhibitor | 0.465 0.038 CID_134772 | CID_134772 | |
| 0.3 | 0.033 | 0.3 | Gastrin inhibitor | 0.263 0.064 CID_134772 | ||
| 0.309 | 0.043 | 0.309 | Potassium channel blocker | 0.151 0.134 CID_134772 | ||
| 0.297 | 0.044 | 0.423 | Psychostimulant | 0.423 0.019 CID_134772 | CID_134772 | |
| 0.285 | 0.059 | 0.294 | Tumour necrosis factor alpha release inhibitor | 0.294 0.056 CID_134772 | CID_134772 | |
| 0.24 | 0.023 | 0.247 | Neurotensin receptor agonist | 0.247 0.022 CID_134772 | CID_134772 | |
| 0.242 | 0.05 | 0.242 | Sigma receptor agonist | 0.214 0.057 CID_134772 | ||
| 0.255 | 0.064 | 0.255 | HERG channel blocker | |||
| 0.246 | 0.093 | 0.252 | Spasmolytic | 0.252 0.09 CID_134772 | CID_134772 | |
| 0.235 | 0.084 | 0.331 | Tyrosine 3 hydroxylase inhibitor | 0.331 0.021 CID_134772 | CID_134772 | |
| 0.172 | 0.033 | 0.204 | Cathepsin H inhibitor | 0.204 0.021 CID_134772 | CID_134772 | |
| 0.245 | 0.109 | 0.245 | Ca(v)3.3 blocker | 0.233 0.128 CID_134772 | ||
| 0.287 | 0.152 | 0.287 | Analgesic | |||
| 0.146 | 0.013 | 0.168 | Lanosterol 14 alpha demethylase inhibitor | 0.168 0.007 CID_134772 | CID_134772 | |
| 0.191 | 0.062 | 0.191 | Lipocortins synthesis antagonist | 0.191 0.062 CID_134772 | ||
| 0.248 | 0.12 | 0.387 | Interleukin 2 agonist | 0.387 0.031 CID_134772 | CID_134772 | |
| 0.295 | 0.17 | 0.364 | 5 Hydroxytryptamine release inhibitor | 0.364 0.104 CID_134772 | CID_134772 | |
| 0.126 | 0.005 | 0.126 | Vanilloid 4 agonist | 0.114 0.009 CID_134772 | ||
| 0.133 | 0.015 | 0.133 | Glutamate release inhibitor | 0.126 0.018 CID_134772 | ||
| 0.214 | 0.097 | 0.232 | Neuropeptide Y2 antagonist | 0.232 0.075 CID_134772 | CID_134772 | |
| 0.129 | 0.021 | 0.129 | Opioid kappa receptor antagonist | 0.089 0.047 CID_134772 | ||
| 0.109 | 0.005 | 0.133 | Prostaglandin EP3 antagonist | 0.133 0.005 CID_134772 | CID_134772 | |
| 0.215 | 0.114 | 0.215 | 5 Hydroxytryptamine 1E antagonist | 0.187 0.146 CID_134772 | ||
| 0.25 | 0.154 | 0.281 | GABA C receptor rho-3 antagonist | 0.281 0.129 CID_134772 | CID_134772 | |
| 0.156 | 0.06 | 0.172 | Cell wall synthesis inhibitor | 0.172 0.046 CID_134772 | CID_134772 | |
| 0.169 | 0.075 | 0.169 | Antipruritic | 0.147 0.097 CID_134772 | ||
| 0.165 | 0.071 | 0.179 | Arachidonic acid antagonist | 0.179 0.054 CID_134772 | CID_134772 | |
| 0.116 | 0.026 | 0.735 | Rho-associated kinase II inhibitor | 0.735 0.003 CID_134772 | CID_134772 | |
| 0.203 | 0.118 | 0.269 | Interleukin agonist | 0.269 0.066 CID_134772 | CID_134772 | |
| 0.122 | 0.039 | 0.122 | Sphingomyelinase inhibitor | 0.1 0.06 CID_134772 | ||
| 0.173 | 0.093 | 0.23 | Non-steroidal antiinflammatory agent | 0.23 0.052 CID_134772 | CID_134772 | |
| 0.179 | 0.099 | 0.179 | Neurotrophic factor enhancer | 0.175 0.103 CID_134772 | ||
| 0.131 | 0.051 | 0.131 | Calcium channel N-type blocker | |||
| 0.091 | 0.017 | 0.105 | Prostaglandin E2 antagonist | 0.105 0.013 CID_134772 | CID_134772 | |
| 0.142 | 0.069 | 0.144 | Pregnane X receptor agonist | 0.144 0.064 CID_134772 | CID_134772 | |
| 0.131 | 0.063 | 0.131 | Nav1.3 sodium channel blocker | 0.1 0.098 CID_134772 | ||
| 0.292 | 0.224 | 0.292 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.161 | 0.094 | 0.215 | Succinate dehydrogenase inhibitor | 0.215 0.038 CID_134772 | CID_134772 | |
| 0.156 | 0.091 | 0.156 | ATPase inhibitor | |||
| 0.072 | 0.009 | 0.072 | Immunoglobulin Fc receptor antagonist | 0.067 0.014 CID_134772 | ||
| 0.17 | 0.108 | 0.17 | Anticonvulsant | 0.15 0.129 CID_134772 | ||
| 0.14 | 0.08 | 0.153 | Adenylate cyclase stimulant | 0.153 0.057 CID_134772 | CID_134772 | |
| 0.101 | 0.047 | 0.101 | Opioid antagonist | 0.083 0.065 CID_134772 | ||
| 0.151 | 0.099 | 0.176 | 3C-like protease (Human coronavirus) inhibitor | 0.176 0.069 CID_134772 | CID_134772 | |
| 0.09 | 0.04 | 0.09 | Estrogen-related receptor beta agonist | 0.081 0.063 CID_134772 | ||
| 0.066 | 0.02 | 0.066 | Purinergic P2X antagonist | 0.065 0.02 CID_134772 | ||
| 0.116 | 0.07 | 0.116 | Anesthetic local | 0.093 0.089 CID_134772 | ||
| 0.124 | 0.079 | 0.128 | Nav1.2 sodium channel blocker | 0.128 0.074 CID_134772 | CID_134772 | |
| 0.072 | 0.028 | 0.094 | Cathepsin L inhibitor | 0.094 0.022 CID_134772 | CID_134772 | |
| 0.059 | 0.016 | 0.092 | Cathepsin L1 inhibitor | 0.092 0.011 CID_134772 | CID_134772 | |
| 0.147 | 0.104 | 0.179 | Tumour necrosis factor antagonist | 0.179 0.068 CID_134772 | CID_134772 | |
| 0.09 | 0.047 | 0.094 | 3C-Like protease (SARS coronavirus) inhibitor | 0.094 0.041 CID_134772 | CID_134772 | |
| 0.098 | 0.056 | 0.116 | Falcipain inhibitor | 0.116 0.046 CID_134772 | CID_134772 | |
| 0.113 | 0.072 | 0.125 | Cholesterol synthesis inhibitor | 0.125 0.061 CID_134772 | CID_134772 | |
| 0.125 | 0.084 | 0.141 | Sphingosine 1-phosphate receptor 2 antagonist | 0.141 0.053 CID_134772 | CID_134772 | |
| 0.095 | 0.055 | 0.113 | Falcipain 2 inhibitor | 0.113 0.045 CID_134772 | CID_134772 | |
| 0.269 | 0.229 | 0.269 | Caspase 9 stimulant | |||
| 0.171 | 0.132 | 0.171 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.051 | 0.019 | 0.056 | Parathyroid hormone antagonist | 0.056 0.014 CID_134772 | CID_134772 | |
| 0.107 | 0.075 | 0.107 | Calcium channel (voltage-sensitive) blocker | |||
| 0.051 | 0.019 | 0.051 | Baculoviral IAP repeat-containing protein inhibitor | |||
| 0.051 | 0.019 | 0.065 | NMDA receptor subunit 3A antagonist | 0.065 0.015 CID_134772 | CID_134772 | |
| 0.083 | 0.053 | 0.083 | Glycine receptor antagonist | 0.082 0.054 CID_134772 | ||
| 0.066 | 0.036 | 0.066 | Beta tubulin antagonist | |||
| 0.128 | 0.099 | 0.139 | Thiol protease inhibitor | 0.139 0.081 CID_134772 | CID_134772 | |
| 0.066 | 0.037 | 0.103 | Neuraminidase inhibitor | 0.103 0.014 CID_134772 | CID_134772 | |
| 0.046 | 0.018 | 0.048 | Cathepsin F inhibitor | 0.048 0.015 CID_134772 | CID_134772 | |
| 0.102 | 0.073 | 0.102 | Alpha 2b adrenoreceptor antagonist | |||
| 0.099 | 0.071 | 0.099 | Falcipain 3 inhibitor | 0.093 0.078 CID_134772 | ||
| 0.217 | 0.189 | 0.226 | Calcium channel activator | 0.226 0.177 CID_134772 | CID_134772 | |
| 0.078 | 0.05 | 0.108 | Sphingosine 1-phosphate receptor antagonist | 0.108 0.017 CID_134772 | CID_134772 | |
| 0.034 | 0.008 | 0.035 | Hedgehog signaling activator | 0.035 0.007 CID_134772 | CID_134772 | |
| 0.047 | 0.021 | 0.047 | Alpha 1L adrenoreceptor agonist | 0.045 0.025 CID_134772 | ||
| 0.061 | 0.035 | 0.061 | Cathepsin B inhibitor | 0.055 0.04 CID_134772 | ||
| 0.05 | 0.023 | 0.071 | Melanocortin 4 antagonist | 0.071 0.015 CID_134772 | CID_134772 | |
| 0.053 | 0.027 | 0.068 | Melanocortin antagonist | 0.068 0.017 CID_134772 | CID_134772 | |
| 0.085 | 0.06 | 0.085 | Ca(v)2.2 blocker | |||
| 0.077 | 0.052 | 0.077 | Analgesic, opioid | |||
| 0.069 | 0.046 | 0.069 | Opioid mu receptor antagonist | |||
| 0.043 | 0.022 | 0.043 | 5-Alpha-reductase inhibitor | |||
| 0.086 | 0.066 | 0.086 | Potassium channel activator | |||
| 0.047 | 0.028 | 0.061 | Neuraminidase (Influenza A) inhibitor | 0.061 0.012 CID_134772 | CID_134772 | |
| 0.092 | 0.075 | 0.101 | Anabolic | 0.101 0.061 CID_134772 | CID_134772 | |
| 0.023 | 0.006 | 0.023 | NMDA receptor phencyclidine site antagonist | 0.018 0.008 CID_134772 | ||
| 0.103 | 0.086 | 0.103 | Microtubule formation inhibitor | 0.099 0.093 CID_134772 | ||
| 0.071 | 0.054 | 0.622 | Rho-associated kinase inhibitor | 0.622 0.004 CID_134772 | CID_134772 | |
| 0.038 | 0.023 | 0.038 | Antibiotic Aminoglycoside-like | |||
| 0.081 | 0.065 | 0.103 | NMDA receptor antagonist | 0.103 0.045 CID_134772 | CID_134772 | |
| 0.065 | 0.049 | 0.065 | Matrix metalloproteinase inhibitor | |||
| 0.122 | 0.107 | 0.122 | CC chemokine 6 receptor antagonist | 0.122 0.109 CID_134772 | ||
| 0.051 | 0.036 | 0.051 | NMDA 2A receptor antagonist | 0.045 0.043 CID_134772 | ||
| 0.048 | 0.033 | 0.053 | Glycine transporter inhibitor | 0.053 0.029 CID_134772 | CID_134772 | |
| 0.112 | 0.097 | 0.112 | Calcium channel blocker | |||
| 0.122 | 0.108 | 0.137 | Insulin secretagoues | 0.137 0.089 CID_134772 | CID_134772 | |
| 0.059 | 0.046 | 0.061 | Cannabinoid CB1 receptor antagonist | 0.061 0.043 CID_134772 | CID_134772 | |
| 0.041 | 0.028 | 0.069 | Kainate receptor agonist | 0.069 0.005 CID_134772 | CID_134772 | |
| 0.062 | 0.049 | 0.094 | Neuraminidase (influenza) inhibitor | 0.094 0.018 CID_134772 | CID_134772 | |
| 0.049 | 0.038 | 0.049 | Potassium channel (Inward rectifier) activator | 0.046 0.045 CID_134772 | ||
| 0.055 | 0.045 | 0.055 | Calcium channel T-type blocker | |||
| 0.051 | 0.041 | 0.051 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.059 | 0.049 | 0.096 | NMDA receptor agonist | 0.096 0.021 CID_134772 | CID_134772 | |
| 0.047 | 0.037 | 0.047 | Potassium channel (ATP-sensitive) activator | |||
| 0.049 | 0.039 | 0.049 | Matrix metalloproteinase 1 inhibitor | |||
| 0.047 | 0.038 | 0.047 | Collagenase inhibitor | |||
| 0.058 | 0.05 | 0.058 | Purinergic P2 antagonist | 0.055 0.054 CID_134772 | ||
| 0.065 | 0.056 | 0.069 | MDM2 inhibitor | 0.069 0.041 CID_134772 | CID_134772 | |
| 0.051 | 0.045 | 0.051 | Matrix metalloproteinase (membrane-type) inhibitor | |||
| 0.077 | 0.071 | 0.077 | Ca(v)3.1 blocker | |||
| 0.033 | 0.027 | 0.033 | Purinergic P2X7 antagonist | |||
| 0.038 | 0.033 | 0.038 | VCAM-1 antagonist | |||
| 0.038 | 0.033 | 0.038 | VCAM antagonist | |||
| 0.036 | 0.031 | 0.036 | Potassium channel Kv1.1 blocker | |||
| 0.023 | 0.017 | 0.024 | CC chemokine 1 receptor antagonist | 0.024 0.016 CID_134772 | CID_134772 | |
| 0.103 | 0.099 | 0.137 | Cyclooxygenase 3 inhibitor | 0.137 0.06 CID_134772 | CID_134772 | |
| 0.021 | 0.017 | 0.021 | Protease (Human cytomegalovirus) inhibitor | |||
| 0.062 | 0.059 | 0.064 | Cannabinoid receptor antagonist | 0.064 0.057 CID_134772 | CID_134772 | |
| 0.109 | 0.106 | 0.127 | Protein kinase stimulant | 0.127 0.086 CID_134772 | CID_134772 | |
| 0.033 | 0.031 | 0.033 | Bombesin 1 receptor antagonist | 0.033 0.03 CID_134772 | ||
| 0.057 | 0.054 | 0.069 | Corticotropin releasing factor 2 receptor antagonist | 0.069 0.03 CID_134772 | CID_134772 | |
| 0.036 | 0.033 | 0.047 | GABA uptake inhibitor | 0.047 0.018 CID_134772 | CID_134772 | |
| 0.083 | 0.08 | 0.084 | ABCA1 expression enhancer | 0.084 0.077 CID_134772 | CID_134772 | |
| 0.057 | 0.055 | 0.057 | Caspase 9 inhibitor | |||
| 0.024 | 0.023 | 0.025 | Cathepsin K inhibitor | 0.025 0.022 CID_134772 | CID_134772 | |
| 0.028 | 0.029 | 0.032 | Glycine transporter 1 inhibitor | 0.032 0.026 CID_134772 | CID_134772 | |
| 0.03 | 0.035 | 0.033 | p53 inhibitor | 0.033 0.027 CID_134772 | CID_134772 | |
| 0.09 | 0.096 | 0.108 | GABA C receptor antagonist | 0.108 0.067 CID_134772 | CID_134772 | |
| 0.033 | 0.04 | 0.036 | Membrane dipeptidase inhibitor | 0.036 0.034 CID_134772 | CID_134772 | |
| 0.032 | 0.039 | 0.047 | Tryptophan 5 hydroxylase inhibitor | 0.047 0.007 CID_134772 | CID_134772 | |
| 0.028 | 0.036 | 0.04 | Glutamate (mGluR3) agonist | 0.04 0.01 CID_134772 | CID_134772 | |
| 0.055 | 0.064 | 0.064 | Protease 3C (Human rhinovirus) inhibitor | 0.064 0.045 CID_134772 | CID_134772 | |
| 0.05 | 0.061 | 0.097 | NMDA 2C receptor antagonist | 0.097 0.017 CID_134772 | CID_134772 | |
| 0.042 | 0.052 | 0.052 | Bombesin 2 receptor antagonist | 0.052 0.031 CID_134772 | CID_134772 | |
| 0.023 | 0.033 | 0.03 | Thrombin receptor antagonist | 0.03 0.017 CID_134772 | CID_134772 | |
| 0.127 | 0.139 | 0.137 | Ca2+-transporting ATPase inhibitor | 0.137 0.084 CID_134772 | CID_134772 | |
| 0.048 | 0.061 | 0.059 | Botulinum neurotoxin type A inhibitor | 0.059 0.039 CID_134772 | CID_134772 | |
| 0.031 | 0.044 | 0.038 | Oxytocin agonist | 0.038 0.034 CID_134772 | CID_134772 | |
| 0.063 | 0.077 | 0.094 | GABA aminotransferase inhibitor | 0.094 0.031 CID_134772 | CID_134772 | |
| 0.018 | 0.033 | 0.027 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.027 0.02 CID_134772 | CID_134772 | |
| 0.155 | 0.17 | 0.377 | Cardiotonic | 0.377 0.033 CID_134772 | CID_134772 | |
| 0.101 | 0.119 | 0.161 | Sphingosine 1-phosphate receptor 4 antagonist | 0.161 0.025 CID_134772 | CID_134772 | |
| 0.049 | 0.068 | 0.072 | Dopamine D1 antagonist | 0.072 0.038 CID_134772 | CID_134772 | |
| 0.072 | 0.091 | 0.124 | Aminopeptidase B inhibitor | 0.124 0.05 CID_134772 | CID_134772 | |
| 0.047 | 0.066 | 0.064 | Sphingosine 1-phosphate receptor 1 antagonist | 0.064 0.024 CID_134772 | CID_134772 | |
| 0.049 | 0.07 | 0.053 | Pregnane X receptor antagonist | 0.053 0.052 CID_134772 | CID_134772 | |
| 0.116 | 0.137 | 0.177 | Sphingosine 1-phosphate receptor 5 antagonist | 0.177 0.026 CID_134772 | CID_134772 | |
| 0.057 | 0.079 | 0.103 | Glutamate (mGluR6) antagonist | 0.103 0.009 CID_134772 | CID_134772 | |
| 0.126 | 0.149 | 0.131 | Heat shock protein 70 antagonist | 0.131 0.116 CID_134772 | CID_134772 | |
| 0.015 | 0.039 | 0.02 | Neuraminidase (Influenza B) inhibitor | 0.02 0.018 CID_134772 | CID_134772 | |
| 0.059 | 0.083 | 0.103 | Glycine receptor agonist | 0.103 0.019 CID_134772 | CID_134772 | |
| 0.024 | 0.05 | 0.036 | Melanocortin 1 antagonist | 0.036 0.028 CID_134772 | CID_134772 | |
| 0.022 | 0.048 | 0.033 | Growth hormone secretagogue receptor antagonist | 0.033 0.027 CID_134772 | CID_134772 | |
| 0.036 | 0.065 | 0.15 | Protein kinase C epsilon inhibitor | 0.15 0.006 CID_134772 | CID_134772 | |
| 0.022 | 0.051 | 0.029 | ATP citrate lysase inhibitor | 0.029 0.027 CID_134772 | CID_134772 | |
| 0.053 | 0.083 | 0.082 | Aminopeptidase I inhibitor | 0.082 0.04 CID_134772 | CID_134772 | |
| 0.017 | 0.052 | 0.037 | Gonadotropin-releasing hormone receptor antagonist | 0.037 0.023 CID_134772 | CID_134772 | |
| 0.022 | 0.061 | 0.038 | Dipeptidyl peptidase II inhibitor | 0.038 0.016 CID_134772 | CID_134772 | |
| 0.033 | 0.077 | 0.043 | Aldosterone antagonist | 0.043 0.042 CID_134772 | CID_134772 | |
| 0.02 | 0.064 | 0.04 | Kinesin-like protein 1 inhibitor | 0.04 0.022 CID_134772 | CID_134772 | |
| 0.02 | 0.064 | 0.04 | Kinesin antagonist | 0.04 0.022 CID_134772 | CID_134772 | |
| 0.034 | 0.079 | 0.051 | Aminopeptidase microsomal inhibitor | 0.051 0.047 CID_134772 | CID_134772 | |
| 0.027 | 0.073 | 0.042 | AMPA 4 receptor antagonist | 0.042 0.023 CID_134772 | CID_134772 | |
| 0.026 | 0.074 | 0.043 | NMDA receptor subunit 3B antagonist | 0.043 0.032 CID_134772 | CID_134772 | |
| 0.072 | 0.121 | 0.088 | Electrolyte absorption antagonist | 0.088 0.078 CID_134772 | CID_134772 | |
| 0.012 | 0.062 | 0.032 | Arginase inhibitor | 0.032 0.029 CID_134772 | CID_134772 | |
| 0.038 | 0.089 | 0.064 | Sphingosine 1-phosphate receptor 3 antagonist | 0.064 0.032 CID_134772 | CID_134772 | |
| 0.045 | 0.097 | 0.068 | Na+ K+ transporting ATPase inhibitor | 0.068 0.062 CID_134772 | CID_134772 | |
| 0.021 | 0.073 | 0.033 | Factor XI inhibitor | 0.033 0.025 CID_134772 | CID_134772 | |
| 0.059 | 0.113 | 0.077 | Inducible nitric-oxide synthase inhibitor | 0.077 0.068 CID_134772 | CID_134772 | |
| 0.042 | 0.098 | 0.072 | Catalase inhibitor | 0.072 0.053 CID_134772 | CID_134772 | |
| 0.139 | 0.196 | 0.164 | Calpain inhibitor | 0.164 0.158 CID_134772 | CID_134772 | |
| 0.151 | 0.209 | 0.21 | Transcription factor STAT3 inhibitor | 0.21 0.121 CID_134772 | CID_134772 | |
| 0.04 | 0.102 | 0.054 | Sphingosine kinase inhibitor | 0.054 0.052 CID_134772 | CID_134772 | |
| 0.05 | 0.116 | 0.076 | Exportin-1 inhibitor | 0.076 0.031 CID_134772 | CID_134772 | |
| 0.062 | 0.129 | 0.102 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.102 0.052 CID_134772 | CID_134772 | |
| 0.013 | 0.083 | 0.035 | Kainate receptor 2 antagonist | 0.035 0.026 CID_134772 | CID_134772 | |
| 0.035 | 0.105 | 0.053 | Sphingosine kinase 2 inhibitor | 0.053 0.042 CID_134772 | CID_134772 | |
| 0.119 | 0.189 | 0.148 | Phospholipase C inhibitor | 0.148 0.111 CID_134772 | CID_134772 | |
| 0.115 | 0.194 | 0.196 | Immunostimulant | 0.196 0.123 CID_134772 | CID_134772 | |
| 0.019 | 0.099 | 0.054 | Glutamate (mGluR3) antagonist | 0.054 0.011 CID_134772 | CID_134772 | |
| 0.026 | 0.113 | 0.052 | Argininosuccinate synthase inhibitor | 0.052 0.045 CID_134772 | CID_134772 | |
| 0.061 | 0.15 | 0.1 | 5 Hydroxytryptamine 3A agonist | 0.1 0.076 CID_134772 | CID_134772 | |
| 0.026 | 0.12 | 0.045 | GABA B receptor antagonist | 0.045 0.026 CID_134772 | CID_134772 | |
| 0.012 | 0.106 | 0.03 | Methionyl aminopeptidase 1 inhibitor | 0.03 0.027 CID_134772 | CID_134772 | |
| 0.028 | 0.126 | 0.043 | Dipeptidyl peptidase IV inhibitor | 0.043 0.032 CID_134772 | CID_134772 | |
| 0.032 | 0.138 | 0.05 | Dipeptidyl peptidase inhibitor | 0.05 0.042 CID_134772 | CID_134772 | |
| 0.145 | 0.252 | 0.199 | Transcription factor STAT inhibitor | 0.199 0.139 CID_134772 | CID_134772 | |
| 0.068 | 0.176 | 0.109 | DOPA decarboxylase inhibitor | 0.109 0.061 CID_134772 | CID_134772 | |
| 0.021 | 0.142 | 0.038 | Glutamate (mGluR8) agonist | 0.038 0.026 CID_134772 | CID_134772 | |
| 0.048 | 0.171 | 0.104 | HIV-1 integrase (Overall Integration) inhibitor | 0.104 0.051 CID_134772 | CID_134772 | |
| 0.02 | 0.159 | 0.045 | Glutamate (mGluR8) antagonist | 0.045 0.012 CID_134772 | CID_134772 | |
| 0.058 | 0.197 | 0.119 | Nav1.4 sodium channel blocker | 0.119 0.053 CID_134772 | CID_134772 | |
| 0.126 | 0.269 | 0.169 | RNA-directed DNA polymerase inhibitor | 0.169 0.153 CID_134772 | CID_134772 | |
| 0.043 | 0.217 | 0.089 | GABA C receptor agonist | 0.089 0.081 CID_134772 | CID_134772 | |
| 0.1 | 0.297 | 0.179 | Superoxide dismutase inhibitor | 0.179 0.143 CID_134772 | CID_134772 | |
| 0.009 | 0.208 | 0.035 | Glutamate (mGluR group II) antagonist | 0.035 0.032 CID_134772 | CID_134772 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |